Through a subcontract with the Radiation Effects Research Foundation (RERF) in Hiroshima and Nagasaki, Japan, the Contractor shall provide access to existing information on cancer mortality and morbidity, radiation dose and other relevent factors among a defined population of atomic bomb survivors in order to facilitate collaborative studies involving the National Cancer Institute, RERF, and other institutions.
| Takeshima, Y; Seyama, T; Bennett, W P et al. (1993) p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342:1520-1 |
| Akiba, S; Neriishi, K; Blot, W J et al. (1991) Serum ferritin and stomach cancer risk among a Japanese population. Cancer 67:1707-12 |
